< 1 minute read
Sep. 18, 2021
Compound 19: An Oral Inhibitor of the Hypoxia-Inducible Factor Propyl Hydroxylase Domain
"Compound 19" (iron-binder)
HIF prolyl hydroxylase domain inhibitor orally active in anemia model from structure-based scaffold hop and opt. ACS Med. Chem. Lett., Jun. 4, 2020 Mitsubishi Tanabe Pharma, Yokohama, JP
Loading...
